Alfred E. SLANETZ

Person

  • Cohasset, MA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Modulated immunodominance therapy

    • Patent number 11,723,921
    • Issue date Aug 15, 2023
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. Slanetz
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20240189353
    • Publication date Jun 13, 2024
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. SLANETZ
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    T CELL COMPOSITIONS FOR IMMUNOTHERAPY

    • Publication number 20230145991
    • Publication date May 11, 2023
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. SLANETZ
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    T CELL COMPOSITIONS FOR IMMUNOTHERAPY

    • Publication number 20200237819
    • Publication date Jul 30, 2020
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. SLANETZ
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20170216357
    • Publication date Aug 3, 2017
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. SLANETZ
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20170101625
    • Publication date Apr 13, 2017
    • Alfred E. Slanetz
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20170043001
    • Publication date Feb 16, 2017
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. Slanetz
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20170043000
    • Publication date Feb 16, 2017
    • GENEIUS BIOTECHNOLOGY, INC.
    • Alfred E. SLANETZ
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20170042998
    • Publication date Feb 16, 2017
    • Alfred E. Slanetz
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    MODULATED IMMUNODOMINANCE THERAPY

    • Publication number 20170042999
    • Publication date Feb 16, 2017
    • Alfred E. Slanetz
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    Modulated Immunodominance Therapy

    • Publication number 20140099341
    • Publication date Apr 10, 2014
    • Alfred E. Slanetz
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    Clinical Outcome-Dependent Medical Intervention Cost Reimbursement...

    • Publication number 20140012594
    • Publication date Jan 9, 2014
    • GENEIUS BIOTECHNOLOGY INVESTMENTS, LLC
    • Alfred E. Slanetz
    • G06 - COMPUTING CALCULATING COUNTING
  • Information Patent Application

    PROCESS FOR DETERMINING TARGET FUNCTION AND IDENTIFYING DRUG LEADS

    • Publication number 20090221436
    • Publication date Sep 3, 2009
    • Alfred E. SLANETZ
    • G06 - COMPUTING CALCULATING COUNTING
  • Information Patent Application

    Process for determining target function and identifying drug leads

    • Publication number 20060234390
    • Publication date Oct 19, 2006
    • Alfred E. Slanetz
    • C40 - COMBINATORIAL CHEMISTRY